Growing Through Challenges? – Cyclacel Pharmaceuticals Inc (CYCC)
Currently, there are 2.15M common shares owned by the public and among those 2.05M shares have been available to trade. The company’s stock has a 5-day price change of 42.50% and -30.91% over the past three months. CYCC shares are trading -57.30% year to date (YTD), with the 12-month market performance down to -89.87% lower. […]
